“Medicines Development for Global Health Secures U.S. FDA Approval For Moxidectin For The Treatment Of River Blindness”
MELBOURNE, GENEVA, and NEW YORK Medicines Development for Global Health (MDGH) and the World Health Organisation Special Programme for Research and Training in Tropical Diseases (TDR) announced today that the United States (U.S.) Food and Drug Administration (FDA) approved moxidectin 8…
Piper Alderman Melbourne has relocated
From 4 June 2018 you will find them at Level 23, 459 Collins Street, Melbourne, 3000 Commencing Monday 4 June 2018, the Melbourne office of Piper Alderman will operate from Level 23, 459 Collins Street, Melbourne. This change will see…
Member news: Success story of a patient on GrunBiotic’s Neurofolin
Member news: Success story of a patient on GrunBiotic’s Neurofolin: https://www.mamamia.com.au/folate-depression/”
AdAlta secures key manufacturing agreements for AD-214
AdAlta secures key manufacturing agreements for AD-214 Please click here for an ASX announcement relating to the execution of key manufacturing agreements for AD-214
Walter and Eliza Hall Institute news: Structure of protein pair provides blueprint for future drugs
Walter and Eliza Hall Institute researchers have visualised for the first time how the protein SOCS1 ‘switches off’ cell signalling to dampen immune responses and block cancer growth. The atomic-level structure of SOCS1 binding to its partner protein…
Women Leading World-Class Health Innovation in Melbourne
Victoria grows globally competitive innovation-intensive companies. Innovation is a people-driven process that thrives on diverse thinking and views. Now that business is embracing the performance-based argument, successful women in and those aspiring towards leadership roles need recognition to…
Australia is backing health innovation industries to build future economy
Announced in the federal budget last night, the 21st century National Medical Industry Growth Plan will deliver $1.3 billion to support Australia as a global health innovation leader in medical technology, biotechnology and pharmaceuticals while improving health outcomes for…
New BioMelbourne Network Board Appointment – David Herd
The BioMelbourne Network Board was delighted to welcome David Herd as new Board Director at the most recent board meeting. “BioMelbourne is a very active and positive contributor to shaping many aspects of our Industry and I am…
BioMelbourne Network gives State Budget 6/10 for the health innovation industry
BioMelbourne Network CEO Dr Krystal Evans welcomes the State Government of Victoria’s Budget yesterday, noting the significant investment in digital infrastructure, the Heart Hospital and the ongoing operational support for the Melbourne Biomedical Precinct. However, these initiatives are…
BioMelbourne Network Policy Principles – 2018 State Election
May 2018 The biotechnology, medical technology and pharmaceutical sector in Victoria is vibrant and growing but yet to reach its full potential contribution to the Victorian economy. Historical support from governments has allowed the sector to grow, now…
AusBiotech announces leadership changes
Mr Glenn Cross retires as AusBiotech’s CEO, and Ms Lorraine Chiroiu appointed as new CEO effective early July 2018 Mr Glenn Cross retirement AusBiotech Chairman, Julie Phillips, has tonight announced that Mr Glenn Cross has decided to retire…
Bioforum Data Focused CRO Opens New Melbourne Office
Company provides local services for companies running R&D activities in Australia Bioforum – the Data Focused CRO and the leading Medidata partner in Israel, servicing research and academic institutes, pharma companies, CROs and startups locally and globally for…
